Skip to main content
OpenTrials

Clinical trial condition

Female Urogenital Diseases

Explore clinical trials studying Female Urogenital Diseases. Study availability and eligibility vary by location and protocol.

22,021 public trials 3,763 recruiting studies
Refine in advanced search Browse all conditions

Female Urogenital Diseases trial results

Recruiting

SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma

NCT05568680

Conditions
Adenoma, Adnexal Diseases, Cholangiocarcinoma Recurrent, +26 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • University of Kansas Cancer Center Westwood, Kansas, United States
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Recruiting

A Study of Abemaciclib and Cabozantinib in People With Clear Cell Renal Cell Carcinoma (ccRCC)

NCT06835972

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
Locations
  • Johns Hopkins University (Data Collection Only) Baltimore, Maryland, United States
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
View Trial Details
Recruiting

SPYRAL GEMINI Pilot Study

NCT06907147

Conditions
Cardiovascular Diseases, Chronic Disease, Chronic Kidney Diseases, +18 more
Locations
  • Stanford Hospital and Clinics Stanford, California, United States
  • Orlando Health Heart & Vascular Institute Orlando, Florida, United States
  • BayCare Health System Mease Countryside Hospital Safety Harbor, Florida, United States
  • Piedmont Heart Institute Atlanta, Georgia, United States
View all 18 locations
View Trial Details
Recruiting

A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study

NCT04641247

Conditions
Adnexal Diseases, Breast Diseases, Breast Neoplasms, +16 more
Locations
  • GSK Investigational Site Tucson, Arizona, United States
  • GSK Investigational Site Encinitas, California, United States
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site Whittier, California, United States
View all 25 locations
View Trial Details

Related conditions